Fig. 1 · Structure
Documents & Downloads
(±)13(14)-EpDPA
DHA Epoxygenase Metabolite
(±)13(14)-EpDPA, a metabolite of docosahexaenoic acid (DHA), is produced through the action of cytochrome P-450 epoxygenase. This compound exhibits notable antihyperalgesic and vasorelaxative effects, making it valuable for research into pain modulation and vascular function. Its biochemical properties support investigations into the therapeutic potential of DHA-derived metabolites in various physiological and pathological contexts.
In Stock
Free Aliquoting for Your Order
Tell us your preferred amount per vial. We’ll confirm the options.
Specifications
| Manufacturer | Adooq Bioscience |
|---|---|
| CAS Number | 895127-64-7 |
| Applications | DHA Epoxygenase Metabolite |
| Formula | C22H32O3 |
| Molecular Weight | 344.49 |
| Synonyms | 13,14-EpDPE |
| SMILES | O=C(O)CC/C=C\C/C=C\C/C=C\CC1OC1C/C=C\C/C=C\CC |
Storage & Solubility
In Vitro Solubility
Reported Solubility
No reported solubility data are available for this product.
Preparing Stock Solutions
| Concentration | |
|---|---|
Values use four significant digits. Prepare to the final solution volume; this is not the volume of solvent to add.
Stock preparation is unavailable for this product molecular weight.
Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.
Storage
Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.